Chanda Sanjay (CIK 0001571820)

Latest company ownership

ANTX - AN2 Therapeutics, Inc.
Role: Chief Development Officer
Shares held
100,500
Last filed at
Feb 28, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 3, 2025 Jan 7, 2025 AN2 Therapeutics, Inc. Chief Development Officer Sell 47.5 -2,957 -9.02% ✗ $4K